| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Chief Operating Officer
1 company
Patel Anish is a Chief Operating Officer at Enliven Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $9.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | ELVN Enliven Therapeutics, Inc. | Chief Operating Officer | Sell | 6,667 | $21.44 | $142,936.48 | -2.0% | +1.8% | +40.2% | |
| Feb 7, 2025 | ELVN Enliven Therapeutics, Inc. | Chief Operating Officer | Sell | 6,667 | $21.93 | $146,205.98 | -2.0% | -15.3% | +33.7% | |
| Jan 7, 2025 | ELVN Enliven Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 28,367 | $24.18 | $685,868.44 | -4.0% | -25.1% | -35.2% | |
| Oct 18, 2024 | ELVN Enliven Therapeutics, Inc. | Chief Operating Officer | Sell | 716 | $30.00 | $21,482.51 | -0.2% | -24.2% | -26.2% | |
| Jul 16, 2024 | ELVN Enliven Therapeutics, Inc. | Chief Operating Officer | Sell | 50,000 | $25.06 | $1,252,826.10 | -4.5% | +12.6% | -12.9% | |
| Jun 6, 2024 | ELVN Enliven Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 1,133 | $20.06 | $22,722.43 | -100% | +7.6% | +2.7% | |
| May 14, 2024 | ELVN Enliven Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 1,107 | $25.00 | $27,675.00 | -100% | -10.7% | -16.7% | |
| May 9, 2024 | ELVN Enliven Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 260 | $25.06 | $6,515.50 | -100% | -9.3% | -22.9% | |
| May 6, 2024 | ELVN Enliven Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 4,875 | $22.72 | $110,769.26 | -100% | -3.5% | -14.1% | |
| Apr 11, 2024 | ELVN Enliven Therapeutics, Inc. | Chief Operating Officer | Sale+OE | 17,500 | $25.03 | $438,098.50 | -100% | -3.2% | -30.7% |